stockportfolio.pro
Moderna, Inc. Shares Outstanding 2016–2025
Moderna, Inc. (MRNA) annual shares outstanding by fiscal year, computed from SEC filings.
| Fiscal year | Shares Outstanding | Change (YoY) |
|---|---|---|
| FY 2025 | 394.0M | +2.1% |
| FY 2024 | 386.0M | +1.0% |
| FY 2023 | 382.0M | -0.8% |
| FY 2022 | 385.0M | -4.5% |
| FY 2021 | 403.0M | +1.0% |
| FY 2020 | 399.0M | +18.6% |
| FY 2019 | 336.5M | +2.4% |
| FY 2018 | 328.8M | +404.2% |
| FY 2017 | 65.2M | — |
| FY 2016 | 0.0M | — |
Source: Moderna, Inc. SEC filings — balance sheet (10-K), split-adjusted. Refreshed nightly.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s shares outstanding?
Moderna, Inc. (MRNA) reported shares outstanding of 394.0M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.